{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:33:36Z","timestamp":1795124016389,"version":"4.10.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2018YFA0108000"],"award-info":[{"award-number":["2018YFA0108000"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2018YFC1314700"],"award-info":[{"award-number":["2018YFC1314700"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172545"],"award-info":[{"award-number":["82172545"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873779"],"award-info":[{"award-number":["81873779"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974196"],"award-info":[{"award-number":["81974196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","award":["20XD1403400"],"award-info":[{"award-number":["20XD1403400"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Sailing Program","award":["22YF1442100"],"award-info":[{"award-number":["22YF1442100"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["22120180511"],"award-info":[{"award-number":["22120180511"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    T lymphocytes are involved in the pathogenesis of Parkinson\u2019s disease (PD), while the heterogeneity of T-cell subpopulations remains elusive. In this study, we analyzed up to 22 subpopulations of T lymphocytes in 115 PD patients and 60 matched healthy controls (HC) using flow cytometry. We found that PD patients exhibited decreased na\u00efve CD8\n                    <jats:sup>+<\/jats:sup>\n                    \u2009T cells (CD3\n                    <jats:sup>+<\/jats:sup>\n                    \u2009CD8\n                    <jats:sup>+<\/jats:sup>\n                    \u2009CD45RA\n                    <jats:sup>+<\/jats:sup>\n                    \u2009CD45RO\n                    <jats:sup>\u2212<\/jats:sup>\n                    ) and increased late-differentiated CD4\n                    <jats:sup>+<\/jats:sup>\n                    \u2009T cells (CD3\n                    <jats:sup>+<\/jats:sup>\n                    \u2009CD4\n                    <jats:sup>+<\/jats:sup>\n                    \u2009CD28\n                    <jats:sup>\u2212<\/jats:sup>\n                    \u00a0CD27\n                    <jats:sup>\u2212<\/jats:sup>\n                    ), compared to HC, which were not affected by anti-parkinsonism medication administration. The proportion of na\u00efve CD8\n                    <jats:sup>+<\/jats:sup>\n                    \u2009T cells in PD patients was positively correlated with their severity of autonomic dysfunction and psychiatric complications, but negatively associated with the severity of rapid eye movement and sleep behavior disorder. The proportion of late-differentiated CD4\n                    <jats:sup>+<\/jats:sup>\n                    \u2009T cells was negatively correlated with the onset age of the disease. We further developed individualized PD risk prediction models with high reliability and accuracy on the base of the T lymphocyte subpopulations. These data suggest that peripheral cellular immunity is disturbed in PD patients, and changes in CD8\n                    <jats:sup>+<\/jats:sup>\n                    \u2009T cells and late-differentiated CD4\n                    <jats:sup>+<\/jats:sup>\n                    \u2009T cells are representative and significant. Therefore, we recommend na\u00efve CD8\u2009+\u2009and late-differentiated CD4\n                    <jats:sup>+<\/jats:sup>\n                    \u2009T cells as candidates for multicentric clinical study and pathomechanism study of PD.\n                  <\/jats:p>","DOI":"10.1007\/s00415-022-11190-z","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T03:02:52Z","timestamp":1653361372000},"page":"5368-5381","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Changes of T lymphocyte subpopulations and their roles in predicting the risk of Parkinson\u2019s disease"],"prefix":"10.1007","volume":"269","author":[{"given":"Yijing","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangwen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghua","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7199-2578","authenticated-orcid":false,"given":"Lingjing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,24]]},"reference":[{"issue":"1","key":"11190_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1172\/JCI36470","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadiere B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, Bonduelle O, Alvarez-Fischer D, Callebert J, Launay JM, Duyckaerts C, Flavell RA, Hirsch EC, Hunot S (2009) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119(1):182\u2013192. https:\/\/doi.org\/10.1172\/JCI36470","journal-title":"J Clin Invest"},{"issue":"3","key":"11190_CR2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.cell.2020.06.026","volume":"182","author":"E Pasciuto","year":"2020","unstructured":"Pasciuto E, Burton OT, Roca CP, Lagou V, Rajan WD, Theys T, Mancuso R, Tito RY, Kouser L, Callaerts-Vegh Z, de la Fuente AG, Prezzemolo T, Mascali LG, Brajic A, Whyte CE, Yshii L, Martinez-Muriana A, Naughton M, Young A, Moudra A, Lemaitre P, Poovathingal S, Raes J, De Strooper B, Fitzgerald DC, Dooley J, Liston A (2020) Microglia require CD4 T cells to complete the fetal-to-adult transition. Cell 182(3):625\u2013640. https:\/\/doi.org\/10.1016\/j.cell.2020.06.026 (e24)","journal-title":"Cell"},{"issue":"7660","key":"11190_CR3","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, Liong C, McMurtrey C, Hildebrand WH, Mao X, Dawson VL, Dawson TM, Oseroff C, Pham J, Sidney J, Dillon MB, Carpenter C, Weiskopf D, Phillips E, Mallal S, Peters B, Frazier A, Lindestam Arlehamn CS, Sette A (2017) T cells from patients with Parkinson\u2019s disease recognize alpha-synuclein peptides. Nature 546(7660):656\u2013661. https:\/\/doi.org\/10.1038\/nature22815","journal-title":"Nature"},{"issue":"1","key":"11190_CR4","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1038\/s41467-020-15626-w","volume":"11","author":"CS Lindestam Arlehamn","year":"2020","unstructured":"Lindestam Arlehamn CS, Dhanwani R, Pham J, Kuan R, Frazier A, Rezende Dutra J, Phillips E, Mallal S, Roederer M, Marder KS, Amara AW, Standaert DG, Goldman JG, Litvan I, Peters B, Sulzer D, Sette A (2020) alpha-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson\u2019s disease. Nat Commun 11(1):1875. https:\/\/doi.org\/10.1038\/s41467-020-15626-w","journal-title":"Nat Commun"},{"issue":"12","key":"11190_CR5","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","volume":"67","author":"S Theodore","year":"2008","unstructured":"Theodore S, Cao S, McLean PJ, Standaert DG (2008) Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. J Neuropathol Exp Neurol 67(12):1149\u20131158. https:\/\/doi.org\/10.1097\/NEN.0b013e31818e5e99","journal-title":"J Neuropathol Exp Neurol"},{"key":"11190_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fimmu.2019.00303","volume":"10","author":"F Garretti","year":"2019","unstructured":"Garretti F, Agalliu D, Lindestam Arlehamn CS, Sette A, Sulzer D (2019) Autoimmunity in Parkinson\u2019s disease: the role of \u03b1-Synuclein-Specific T cells. Front Immunol 10:303. https:\/\/doi.org\/10.3389\/fimmu.2019.00303","journal-title":"Front Immunol"},{"issue":"7","key":"11190_CR7","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/brain\/awab103","volume":"144","author":"GP Williams","year":"2021","unstructured":"Williams GP, Schonhoff AM, Jurkuvenaite A, Gallups NJ, Standaert DG, Harms AS (2021) CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease. Brain 144(7):2047\u20132059. https:\/\/doi.org\/10.1093\/brain\/awab103","journal-title":"Brain"},{"issue":"12","key":"11190_CR8","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1093\/brain\/awaa269","volume":"143","author":"J Galiano-Landeira","year":"2020","unstructured":"Galiano-Landeira J, Torra A, Vila M, Bove J (2020) CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson\u2019s disease. Brain 143(12):3717\u20133733. https:\/\/doi.org\/10.1093\/brain\/awaa269","journal-title":"Brain"},{"key":"11190_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab103","author":"GP Williams","year":"2021","unstructured":"Williams GP, Schonhoff AM, Jurkuvenaite A, Gallups NJ, Standaert DG, Harms AS (2021) CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson disease. Brain. https:\/\/doi.org\/10.1093\/brain\/awab103","journal-title":"Brain"},{"issue":"5","key":"11190_CR10","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1189\/jlb.0507296","volume":"82","author":"AD Reynolds","year":"2007","unstructured":"Reynolds AD, Banerjee R, Liu J, Gendelman HE, Mosley RL (2007) Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson\u2019s disease. J Leukoc Biol 82(5):1083\u20131094. https:\/\/doi.org\/10.1189\/jlb.0507296","journal-title":"J Leukoc Biol"},{"issue":"2","key":"11190_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/ana.20369","volume":"57","author":"R Kortekaas","year":"2005","unstructured":"Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT, Hendrikse NH (2005) Blood-brain barrier dysfunction in Parkinsonian midbrain in vivo. Ann Neurol 57(2):176\u2013179. https:\/\/doi.org\/10.1002\/ana.20369","journal-title":"Ann Neurol"},{"issue":"7560","key":"11190_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, Derecki NC, Castle D, Mandell JW, Lee KS, Harris TH, Kipnis J (2015) Structural and functional features of central nervous system lymphatic vessels. Nature 523(7560):337\u2013341. https:\/\/doi.org\/10.1038\/nature14432","journal-title":"Nature"},{"issue":"4","key":"11190_CR13","doi-asserted-by":"publisher","first-page":"6105","DOI":"10.3892\/mmr.2015.4136","volume":"12","author":"Y Chen","year":"2015","unstructured":"Chen Y, Qi B, Xu W, Ma B, Li L, Chen Q, Qian W, Liu X, Qu H (2015) Clinical correlation of peripheral CD4+cell subsets, their imbalance and Parkinson\u2019s disease. Mol Med Rep 12(4):6105\u20136111. https:\/\/doi.org\/10.3892\/mmr.2015.4136","journal-title":"Mol Med Rep"},{"issue":"1","key":"11190_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","volume":"15","author":"N Kustrimovic","year":"2018","unstructured":"Kustrimovic N, Comi C, Magistrelli L, Rasini E, Legnaro M, Bombelli R, Aleksic I, Blandini F, Minafra B, Riboldazzi G, Sturchio A, Mauri M, Bono G, Marino F, Cosentino M (2018) Parkinson\u2019s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-naive and drug-treated patients. J Neuroinflammation 15(1):205. https:\/\/doi.org\/10.1186\/s12974-018-1248-8","journal-title":"J Neuroinflammation"},{"issue":"8","key":"11190_CR15","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s10072-017-2988-4","volume":"38","author":"S Jiang","year":"2017","unstructured":"Jiang S, Gao H, Luo Q, Wang P, Yang X (2017) The correlation of lymphocyte subsets, natural killer cell, and Parkinson\u2019s disease: a meta-analysis. Neurol Sci 38(8):1373\u20131380. https:\/\/doi.org\/10.1007\/s10072-017-2988-4","journal-title":"Neurol Sci"},{"key":"11190_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neulet.2017.03.045","volume":"648","author":"S Chen","year":"2017","unstructured":"Chen S, Liu Y, Niu Y, Xu Y, Zhou Q, Xu X, Wang J, Yu M (2017) Increased abundance of myeloid-derived suppressor cells and Th17 cells in peripheral blood of newly-diagnosed Parkinson\u2019s disease patients. Neurosci Lett 648:21\u201325. https:\/\/doi.org\/10.1016\/j.neulet.2017.03.045","journal-title":"Neurosci Lett"},{"issue":"4","key":"11190_CR17","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s11481-012-9402-z","volume":"7","author":"JA Saunders","year":"2012","unstructured":"Saunders JA, Estes KA, Kosloski LM, Allen HE, Dempsey KM, Torres-Russotto DR, Meza JL, Santamaria PM, Bertoni JM, Murman DL, Ali HH, Standaert DG, Mosley RL, Gendelman HE (2012) CD4+ regulatory and effector\/memory T cell subsets profile motor dysfunction in Parkinson\u2019s disease. J Neuroimmune Pharmacol 7(4):927\u2013938. https:\/\/doi.org\/10.1007\/s11481-012-9402-z","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1\u20132","key":"11190_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jneuroim.2010.12.001","volume":"233","author":"MA Gruden","year":"2011","unstructured":"Gruden MA, Sewell RD, Yanamandra K, Davidova TV, Kucheryanu VG, Bocharov EV, Bocharova OA, Polyschuk VV, Sherstnev VV, Morozova-Roche LA (2011) Immunoprotection against toxic biomarkers is retained during Parkinson\u2019s disease progression. J Neuroimmunol 233(1\u20132):221\u2013227. https:\/\/doi.org\/10.1016\/j.jneuroim.2010.12.001","journal-title":"J Neuroimmunol"},{"issue":"2","key":"11190_CR19","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1007\/s12035-017-0404-y","volume":"55","author":"NP Rocha","year":"2018","unstructured":"Rocha NP, Assis F, Scalzo PL, Vieira ELM, Barbosa IG, de Souza MS, Christo PP, Reis HJ, Teixeira AL (2018) Reduced activated T lymphocytes (CD4+CD25+) and plasma levels of cytokines in Parkinson\u2019s disease. Mol Neurobiol 55(2):1488\u20131497. https:\/\/doi.org\/10.1007\/s12035-017-0404-y","journal-title":"Mol Neurobiol"},{"issue":"1","key":"11190_CR20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1447-0594.2011.00740.x","volume":"12","author":"F Niwa","year":"2012","unstructured":"Niwa F, Kuriyama N, Nakagawa M, Imanishi J (2012) Effects of peripheral lymphocyte subpopulations and the clinical correlation with Parkinson\u2019s disease. Geriatr Gerontol Int 12(1):102\u2013107. https:\/\/doi.org\/10.1111\/j.1447-0594.2011.00740.x","journal-title":"Geriatr Gerontol Int"},{"issue":"2","key":"11190_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/0022-510x(95)00136-p","volume":"132","author":"S Chiba","year":"1995","unstructured":"Chiba S, Matsumoto H, Saitoh M, Kasahara M, Matsuya M, Kashiwagi M (1995) A correlation study between serum adenosine deaminase activities and peripheral lymphocyte subsets in Parkinson\u2019s disease. J Neurol Sci 132(2):170\u2013173. https:\/\/doi.org\/10.1016\/0022-510x(95)00136-p","journal-title":"J Neurol Sci"},{"issue":"8","key":"11190_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","volume":"11","author":"Y Baba","year":"2005","unstructured":"Baba Y, Kuroiwa A, Uitti RJ, Wszolek ZK, Yamada T (2005) Alterations of T-lymphocyte populations in Parkinson disease. Parkinsonism Relat Disord 11(8):493\u2013498. https:\/\/doi.org\/10.1016\/j.parkreldis.2005.07.005","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"11190_CR23","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"4","key":"11190_CR24","first-page":"374","volume":"19","author":"GC Salzman","year":"1975","unstructured":"Salzman GC, Crowell JM, Martin JC, Trujillo TT, Romero A, Mullaney PF, LaBauve PM (1975) Cell classification by laser light scattering: identification and separation of unstained leukocytes. Acta Cytol 19(4):374\u2013377","journal-title":"Acta Cytol"},{"issue":"9","key":"11190_CR25","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1089\/ARS.2009.2460","volume":"11","author":"DK Stone","year":"2009","unstructured":"Stone DK, Reynolds AD, Mosley RL, Gendelman HE (2009) Innate and adaptive immunity for the pathobiology of Parkinson\u2019s disease. Antioxid Redox Signal 11(9):2151\u20132166. https:\/\/doi.org\/10.1089\/ARS.2009.2460","journal-title":"Antioxid Redox Signal"},{"issue":"6370","key":"11190_CR26","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/356607a0","volume":"356","author":"FA Harding","year":"1992","unstructured":"Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP (1992) CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356(6370):607\u2013609. https:\/\/doi.org\/10.1038\/356607a0","journal-title":"Nature"},{"issue":"5","key":"11190_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/80877","volume":"1","author":"J Hendriks","year":"2000","unstructured":"Hendriks J, Gravestein LA, Tesselaar K, van Lier RA, Schumacher TN, Borst J (2000) CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol 1(5):433\u2013440. https:\/\/doi.org\/10.1038\/80877","journal-title":"Nat Immunol"},{"issue":"1","key":"11190_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.18683\/germs.2021.1242","volume":"11","author":"L Banica","year":"2021","unstructured":"Banica L, Vlaicu O, Jipa R, Abagiu A, Nicolae I, Neaga E, Otelea D, Paraschiv S (2021) Exhaustion and senescence of CD4 and CD8 T cells that express co-stimulatory molecules CD27 and CD28 in subjects that acquired HIV by drug use or by sexual route. Germs 11(1):66\u201377. https:\/\/doi.org\/10.18683\/germs.2021.1242","journal-title":"Germs"},{"issue":"12","key":"11190_CR29","doi-asserted-by":"publisher","first-page":"8218","DOI":"10.4049\/jimmunol.175.12.8218","volume":"175","author":"JM Fletcher","year":"2005","unstructured":"Fletcher JM, Vukmanovic-Stejic M, Dunne PJ, Birch KE, Cook JE, Jackson SE, Salmon M, Rustin MH, Akbar AN (2005) Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol 175(12):8218\u20138225. https:\/\/doi.org\/10.4049\/jimmunol.175.12.8218","journal-title":"J Immunol"},{"issue":"1","key":"11190_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2567.2011.03470.x","volume":"134","author":"M Strioga","year":"2011","unstructured":"Strioga M, Pasukoniene V, Characiejus D (2011) CD8+ CD28\u2212 and CD8+ CD57+ T cells and their role in health and disease. Immunology 134(1):17\u201332. https:\/\/doi.org\/10.1111\/j.1365-2567.2011.03470.x","journal-title":"Immunology"},{"issue":"2","key":"11190_CR31","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.virol.2009.11.038","volume":"398","author":"A Tovar-Salazar","year":"2010","unstructured":"Tovar-Salazar A, Patterson-Bartlett J, Jesser R, Weinberg A (2010) Regulatory function of cytomegalovirus-specific CD4+CD27\u2212CD28\u2212 T cells. Virology 398(2):158\u2013167. https:\/\/doi.org\/10.1016\/j.virol.2009.11.038","journal-title":"Virology"},{"key":"11190_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-020-00806-z","author":"F Barbe-Tuana","year":"2020","unstructured":"Barbe-Tuana F, Funchal G, Schmitz CRR, Maurmann RM, Bauer ME (2020) The interplay between immunosenescence and age-related diseases. Semin Immunopathol. https:\/\/doi.org\/10.1007\/s00281-020-00806-z","journal-title":"Semin Immunopathol"},{"issue":"12","key":"11190_CR33","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.it.2016.09.002","volume":"37","author":"AN Akbar","year":"2016","unstructured":"Akbar AN, Henson SM, Lanna A (2016) Senescence of T lymphocytes: implications for enhancing human immunity. Trends Immunol 37(12):866\u2013876. https:\/\/doi.org\/10.1016\/j.it.2016.09.002","journal-title":"Trends Immunol"},{"issue":"3","key":"11190_CR34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1600-0404.1994.tb02699.x","volume":"90","author":"U Fiszer","year":"1994","unstructured":"Fiszer U, Mix E, Fredrikson S, Kostulas V, Link H (1994) Parkinson\u2019s disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood. Acta Neurol Scand 90(3):160\u2013166. https:\/\/doi.org\/10.1111\/j.1600-0404.1994.tb02699.x","journal-title":"Acta Neurol Scand"},{"issue":"1\u20132","key":"11190_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jneuroim.2012.07.015","volume":"252","author":"CH Stevens","year":"2012","unstructured":"Stevens CH, Rowe D, Morel-Kopp MC, Orr C, Russell T, Ranola M, Ward C, Halliday GM (2012) Reduced T helper and B lymphocytes in Parkinson\u2019s disease. J Neuroimmunol 252(1\u20132):95\u201399. https:\/\/doi.org\/10.1016\/j.jneuroim.2012.07.015","journal-title":"J Neuroimmunol"},{"issue":"5","key":"11190_CR36","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s12264-017-0163-9","volume":"33","author":"L Cen","year":"2017","unstructured":"Cen L, Yang C, Huang S, Zhou M, Tang X, Li K, Guo W, Wu Z, Mo M, Xiao Y, Chen X, Yang X, Huang Q, Chen C, Qu S, Xu P (2017) Peripheral lymphocyte subsets as a marker of Parkinson\u2019s disease in a Chinese population. Neurosci Bull 33(5):493\u2013500. https:\/\/doi.org\/10.1007\/s12264-017-0163-9","journal-title":"Neurosci Bull"},{"issue":"4","key":"11190_CR37","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.coi.2012.04.001","volume":"24","author":"SM Henson","year":"2012","unstructured":"Henson SM, Riddell NE, Akbar AN (2012) Properties of end-stage human T cells defined by CD45RA re-expression. Curr Opin Immunol 24(4):476\u2013481. https:\/\/doi.org\/10.1016\/j.coi.2012.04.001","journal-title":"Curr Opin Immunol"},{"key":"11190_CR38","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001036","author":"Z Yan","year":"2021","unstructured":"Yan Z, Yang W, Wei H, Dean MN, Standaert DG, Cutter GR, Benveniste EN, Qin H (2021) Dysregulation of the adaptive immune system in patients with early-stage Parkinson disease. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000001036","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"11190_CR39","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12967-021-03055-2","volume":"19","author":"DD Alvarez-Luquin","year":"2021","unstructured":"Alvarez-Luquin DD, Guevara-Salinas A, Arce-Sillas A, Espinosa-Cardenas R, Leyva-Hernandez J, Montes-Moratilla EU, Adalid-Peralta L (2021) Increased Tc17 cell levels and imbalance of naive\/effector immune response in Parkinson\u2019s disease patients in a two-year follow-up: a case control study. J Transl Med 19(1):378. https:\/\/doi.org\/10.1186\/s12967-021-03055-2","journal-title":"J Transl Med"},{"issue":"9","key":"11190_CR40","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.4049\/jimmunol.1500046","volume":"194","author":"JJ Goronzy","year":"2015","unstructured":"Goronzy JJ, Fang F, Cavanagh MM, Qi Q, Weyand CM (2015) Naive T cell maintenance and function in human aging. J Immunol 194(9):4073\u20134080. https:\/\/doi.org\/10.4049\/jimmunol.1500046","journal-title":"J Immunol"},{"key":"11190_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev-immunol-032712-095954","volume":"31","author":"SN Mueller","year":"2013","unstructured":"Mueller SN, Gebhardt T, Carbone FR, Heath WR (2013) Memory T cell subsets, migration patterns, and tissue residence. Annu Rev Immunol 31:137\u2013161. https:\/\/doi.org\/10.1146\/annurev-immunol-032712-095954","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"11190_CR42","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/mds.27815","volume":"34","author":"SK Nissen","year":"2019","unstructured":"Nissen SK, Shrivastava K, Schulte C, Otzen DE, Goldeck D, Berg D, Moller HJ, Maetzler W, Romero-Ramos M (2019) Alterations in blood monocyte functions in Parkinson\u2019s disease. Mov Disord 34(11):1711\u20131721. https:\/\/doi.org\/10.1002\/mds.27815","journal-title":"Mov Disord"},{"issue":"6","key":"11190_CR43","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/ana.25614","volume":"86","author":"S Yazdani","year":"2019","unstructured":"Yazdani S, Mariosa D, Hammar N, Andersson J, Ingre C, Walldius G, Fang F (2019) Peripheral immune biomarkers and neurodegenerative diseases: a prospective cohort study with 20 years of follow-up. Ann Neurol 86(6):913\u2013926. https:\/\/doi.org\/10.1002\/ana.25614","journal-title":"Ann Neurol"},{"key":"11190_CR44","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3389\/fnins.2019.01057","volume":"13","author":"C Sun","year":"2019","unstructured":"Sun C, Yu W, Zhao Z, Song C, Liu Y, Jia G, Wang X, Liu Y (2019) Peripheral humoral immune response is associated with the non-motor symptoms of Parkinson\u2019s disease. Front Neurosci 13:1057. https:\/\/doi.org\/10.3389\/fnins.2019.01057","journal-title":"Front Neurosci"},{"issue":"47","key":"11190_CR45","first-page":"3726","volume":"94","author":"S Zhang","year":"2014","unstructured":"Zhang S, Sun C, Zhang L, Cen L, Mo M, Liu Z, Huang W, Zhu F, Kang P, Chen Z, Yi L, Xu P (2014) Clinical analysis of subpopulation of peripheral T and B lymphocytes in Chinese Parkinson\u2019s disease patients. Zhonghua Yi Xue Za Zhi 94(47):3726\u20133730","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"22","key":"11190_CR46","doi-asserted-by":"publisher","first-page":"637","DOI":"10.21037\/atm.2019.10.105","volume":"7","author":"C Sun","year":"2019","unstructured":"Sun C, Zhao Z, Yu W, Mo M, Song C, Si Y, Liu Y (2019) Abnormal subpopulations of peripheral blood lymphocytes are involved in Parkinson\u2019s disease. Ann Transl Med 7(22):637. https:\/\/doi.org\/10.21037\/atm.2019.10.105","journal-title":"Ann Transl Med"},{"issue":"6","key":"11190_CR47","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1176\/appi.psy.51.6.474","volume":"51","author":"M Menza","year":"2010","unstructured":"Menza M, Dobkin RD, Marin H, Mark MH, Gara M, Bienfait K, Dicke A, Kusnekov A (2010) The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson\u2019s disease. Psychosomatics 51(6):474\u2013479. https:\/\/doi.org\/10.1176\/appi.psy.51.6.474","journal-title":"Psychosomatics"},{"key":"11190_CR48","doi-asserted-by":"publisher","first-page":"2072635","DOI":"10.1155\/2019\/2072635","volume":"2019","author":"S Jiang","year":"2019","unstructured":"Jiang S, Wang Y, Gao H, Luo Q, Wang D, Li Y, Yong Y, Yang X (2019) Cell ratio differences in peripheral blood between early- and late-onset Parkinson\u2019s disease: a case-control study. Biomed Res Int 2019:2072635. https:\/\/doi.org\/10.1155\/2019\/2072635","journal-title":"Biomed Res Int"},{"issue":"4","key":"11190_CR49","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP (2015) Nomograms in oncology: more than meets the eye. Lancet Oncol 16(4):e173\u2013e180. https:\/\/doi.org\/10.1016\/S1470-2045(14)71116-7","journal-title":"Lancet Oncol"},{"issue":"4","key":"11190_CR50","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.18632\/aging.202443","volume":"13","author":"Y Tang","year":"2021","unstructured":"Tang Y, Wang J, Chen G, Ye W, Yan N, Feng Z (2021) A simple-to-use web-based calculator for survival prediction in Parkinson\u2019s disease. Aging (Albany NY) 13(4):5238\u20135249. https:\/\/doi.org\/10.18632\/aging.202443","journal-title":"Aging (Albany NY)"},{"key":"11190_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.548616","volume":"12","author":"Z Shu","year":"2020","unstructured":"Shu Z, Pang P, Wu X, Cui S, Xu Y, Zhang M (2020) An integrative nomogram for identifying early-stage Parkinson\u2019s disease using non-motor symptoms and white matter-based radiomics biomarkers from whole-brain MRI. Front Aging Neurosci 12:548616. https:\/\/doi.org\/10.3389\/fnagi.2020.548616","journal-title":"Front Aging Neurosci"},{"key":"11190_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2015.12.008","volume":"23","author":"V Bellou","year":"2016","unstructured":"Bellou V, Belbasis L, Tzoulaki I, Evangelou E, Ioannidis JP (2016) Environmental risk factors and Parkinson\u2019s disease: an umbrella review of meta-analyses. Parkinsonism Relat Disord 23:1\u20139. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.12.008","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11190-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11190-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11190-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T12:16:25Z","timestamp":1662984985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11190-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["11190"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11190-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,24]]},"assertion":[{"value":"22 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the Ethics Committee of Tongji Hospital of Tongji University (Approved ID: KYSB-2017-097). All the participants signed informed consent before enrollment. The study was performed according to the Declaration of Helsinki and the relevant ethical guidelines for research on humans.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}